Table 1.
Characteristics of patients and place of death
|
Diagnosis
1
|
Diagnosed (01/09/04-31/08/10) |
Deceased (by 31/08/12) |
Place of death |
||||
|---|---|---|---|---|---|---|---|
|
N |
Median age at diagnosis |
N (% of those diagnosed) |
Hospital |
Home |
Nursing home |
Hospice |
|
| N (% of deaths) | N (% of deaths) | N (% of deaths) | N (% of deaths) | ||||
|
Total |
10325 |
70.9 |
4829 (46.8) |
3183 (65.9) |
753 (15.6) |
532 (11.0) |
361 (7.5) |
| Myeloma |
1399 |
73.0 |
887 (63.4) |
572 (64.5) |
139 (15.7) |
107 (12.0) |
69 (7.8) |
| Diffuse large B-cell lymphoma |
1604 |
70.4 |
831 (51.8) |
535 (64.5) |
122 (14.7) |
94 (11.3) |
80 (9.6) |
| Myelodysplastic syndromes |
794 |
76.0 |
595 (74.9) |
422 (70.9) |
94 (15.8) |
44 (7.4) |
35 (5.9) |
| Acute myeloid leukaemia |
722 |
71.1 |
573 (79.4) |
413 (72.1) |
81 (14.1) |
41 (7.2) |
38 (6.6) |
| Chronic lymphocytic leukaemia |
1279 |
71.6 |
424 (33.2) |
276 (65.1) |
74 (17.5) |
50 (11.8) |
24 (5.6) |
| Myeloproliferative neoplasms |
1187 |
71.2 |
283 (23.8) |
161 (56.9) |
50 (17.7) |
53 (18.7) |
19 (6.7) |
| Marginal zone lymphoma |
625 |
72.2 |
229 (36.6) |
141 (61.6) |
28 (12.2) |
42 (18.3) |
18 (7.9) |
| Lymphoproliferative disorder NOS2 |
378 |
77.0 |
165 (43.7) |
101 (61.2) |
26 (15.8) |
30 (18.2) |
8 (4.8) |
| Follicular lymphoma |
656 |
64.5 |
148 (22.6) |
91 (61.5) |
29 (19.6) |
16 (10.8) |
12 (8.1) |
| Hodgkin lymphoma |
576 |
44.4 |
126 (21.9) |
94 (74.6) |
17 (13.5) |
10 (7.9) |
5 (4.0) |
| Mantle cell lymphoma |
173 |
74.0 |
123 (71.1) |
66 (53.7) |
24 (19.5) |
13 (10.6) |
20 (16.2) |
| T-cell lymphoma |
206 |
64.9 |
117 (56.8) |
83 (70.9) |
20 (17.1) |
5 (4.3) |
9 (7.7) |
| Chronic myelomonocytic leukaemia |
127 |
77.4 |
89 (70.1) |
64 (71.9) |
16 (18.0) |
7 (7.9) |
2 (2.2) |
| Acute lymphoblastic leukaemia |
112 |
47.5 |
77 (68.8) |
53 (68.8) |
10 (13.0) |
4 (5.2) |
10 (13.0) |
| Primary myelofibrosis |
88 |
74.1 |
49 (55.7) |
34 (69.4) |
8 (16.3) |
3 (6.1) |
4 (8.2) |
| Chronic myeloid leukaemia |
203 |
59.2 |
44 (21.7) |
32 (72.7) |
4 (9.1) |
5 (11.4) |
3 (6.8) |
| Burkitt lymphoma |
53 |
57.6 |
30 (56.6) |
21 (70.0) |
5 (16.6) |
2 (6.7) |
2 (6.7) |
| T-cell leukaemia |
80 |
74.7 |
30 (37.5) |
19 (63.3) |
4 (13.3) |
5 (16.7) |
2 (6.7) |
| Hairy cell leukaemia | 63 | 65.5 | 9 (14.3) | 5 (55.6) | 2 (22.2) | 1 (11.1) | 1 (11.1) |
1Ordered by absolute number of deaths; 2Not otherwise specified.